Show simple item record

dc.contributor.authorFreathy, RM
dc.contributor.authorWeedon, Michael N.
dc.contributor.authorMelzer, D
dc.contributor.authorShields, B
dc.contributor.authorHitman, Graham A.
dc.contributor.authorWalker, M
dc.contributor.authorMcCarthy, MI
dc.contributor.authorHattersley, Andrew T.
dc.contributor.authorFrayling, Timothy M.
dc.date.accessioned2016-02-23T15:42:19Z
dc.date.issued2006-06-05
dc.description.abstractBACKGROUND: Klotho has an important role in insulin signalling and the development of ageing-like phenotypes in mice. The common functional "KL-VS" variant in the KLOTHO (KL) gene is associated with longevity in humans but its role in type 2 diabetes is not known. We performed a large case-control and family-based study to test the hypothesis that KL-VS is associated with type 2 diabetes in a UK Caucasian population. METHODS: We genotyped 1793 cases, 1619 controls and 1616 subjects from 509 families for the single nucleotide polymorphism (SNP) F352V (rs9536314) that defines the KL-VS variant. Allele and genotype frequencies were compared between cases and controls. Family-based analysis was used to test for over- or under-transmission of V352 to affected offspring. RESULTS: Despite good power to detect odds ratios of 1.2, there were no significant associations between alleles or genotypes and type 2 diabetes (V352 allele: odds ratio = 0.96 (0.84-1.09)). Additional analysis of quantitative trait data in 1177 healthy control subjects showed no association of the variant with fasting insulin, glucose, triglycerides, HDL- or LDL-cholesterol (all P > 0.05). However, the HDL-cholesterol levels observed across the genotype groups showed a similar, but non-significant, pattern to previously reported data. CONCLUSION: This is the first large-scale study to examine the association between common functional variation in KL and type 2 diabetes risk. We have found no evidence that the functional KL-VS variant is a risk factor for type 2 diabetes in a large UK Caucasian case-control and family-based study.en_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.description.sponsorshipVandervell Foundationen_GB
dc.identifier.citationVol. 7, pp. 51 -en_GB
dc.identifier.doi10.1186/1471-2350-7-51
dc.identifier.other1471-2350-7-51
dc.identifier.urihttp://hdl.handle.net/10871/20092
dc.language.isoenen_GB
dc.publisherBioMed Centralen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/16753056en_GB
dc.relation.urlhttp://bmcmedgenet.biomedcentral.com/articles/10.1186/1471-2350-7-51en_GB
dc.rightsCopyright © Freathy et al; licensee BioMed Central Ltd. 2006. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectAdulten_GB
dc.subjectCase-Control Studiesen_GB
dc.subjectDiabetes Mellitus, Type 2en_GB
dc.subjectEuropean Continental Ancestry Groupen_GB
dc.subjectFemaleen_GB
dc.subjectGene Frequencyen_GB
dc.subjectGenetic Predisposition to Diseaseen_GB
dc.subjectGlucuronidaseen_GB
dc.subjectGreat Britainen_GB
dc.subjectHumansen_GB
dc.subjectMaleen_GB
dc.subjectMiddle Ageden_GB
dc.subjectPolymorphism, Single Nucleotideen_GB
dc.titleThe functional "KL-VS" variant of KLOTHO is not associated with type 2 diabetes in 5028 UK Caucasians.en_GB
dc.typeArticleen_GB
dc.date.available2016-02-23T15:42:19Z
dc.identifier.issn1471-2350
exeter.place-of-publicationEngland
dc.descriptionPublished onlineen_GB
dc.descriptionJournal Articleen_GB
dc.descriptionResearch Support, Non-U.S. Gov'ten_GB
dc.identifier.journalBMC Medical Geneticsen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record